PhoreMost
Cambridge, Massachusetts, United States · Biopharma, Biotechnology, Pharmaceutical
PhoreMost is a biopharmaceutical company specializing in the development of next-generation drug targets through its innovative SITESEEKER platform. The company focuses on degrader programs, particularly in oncology and inflammatory diseases. With recent funding, it aims to advance its pipeline of novel degrader assets toward preclinical development. PhoreMost is committed to revolutionizing medic
Key facts
- Headquarters
- Cambridge, Massachusetts, United States
- Employees
- 32
- Industries
- Biopharma, Biotechnology, Pharmaceutical
- Status
- Private
- Website
- www.phoremost.com
- Company page
Recent activity at PhoreMost
PhoreMost funding history
| Date | Round | Amount |
|---|---|---|
| Sep 2024 | Series B | $9.0M |
Leadership
- Gabriel Fox, Chief Medical Officer
- Benedict Cross, Chief Technology Officer
- Margot Holmes, Finance Assistant
- Jeremy Thomas, Finance Director
- Neil Torbett, Biotechnology Professional
- Charli Howes
- Ian Hutchison
Verified email and direct lines for PhoreMost’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
PhoreMost in the news
- PhoreMost announces lead oncology program and appoints Chief Medical Officer to support clinical entry - News-Medical (Jun 12, 2026)
- PhoreMost demonstrates new approach to rationalise molecular glue drug discovery - Cambridge Network (Jul 22, 2025)
- PhoreMost Achieves Second Milestone in Target Discovery Alliance with Boehringer Ingelheim - Business Wire (Jun 03, 2024)
- PhoreMost Introduces GlueSEEKER Platform for Discovery of Molecular Glue Degraders - Business Wire (May 21, 2024)
Companies similar to PhoreMost
- Acellera Therapeutics and Psivant Therapeutics · Biopharma, Biotechnology, Pharmaceutical, Therapeutics
- Cumulus Oncology · Biopharma, Biotechnology, Pharmaceutical, Therapeutics
- Arecor Therapeutics PLC · Biopharma, Biotechnology, Pharmaceutical, Therapeutics
- Windward Bio · Biopharma, Biotechnology, Pharmaceutical, Therapeutics
- OnKure Therapeutics · Biopharma, Biotechnology, Pharmaceutical, Therapeutics
About PhoreMost: questions and answers
What does PhoreMost do?
PhoreMost is a biopharmaceutical company specializing in the development of next-generation drug targets through its innovative SITESEEKER platform. The company focuses on degrader programs, particularly in oncology and inflammatory diseases. With recent funding, it aims to advance its pipeline of novel degrader assets toward preclinical development. PhoreMost is committed to revolutionizing medic
Where is PhoreMost headquartered?
PhoreMost is headquartered in Cambridge, Massachusetts, United States.
How many employees does PhoreMost have?
PhoreMost has about 32 employees.
Has PhoreMost raised funding?
Yes. Fundz has recorded 1 funding event for PhoreMost. The most recent, Series B of $9.0M, was in Sep 2024.
What is the latest news on PhoreMost?
On Jun 10, 2026, PhoreMost Appoints Gabriel Fox as Chief Medical Officer
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy